Muvalaplin shows promise in lowering Lp(a) levels in clinical trial
A clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of lipoprotein ...
A clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of lipoprotein ...
Researchers at the University of Bern and Bern University Hospital have developed a test to simplify the diagnosis of allergies. ...
A new type of blood test using lipids could make it easier to identify children at risk of complications around ...
Cognitive behavioral therapy, one of the most common treatments for depression, can teach skills for coping with everyday troubles, reinforce ...
People with multiple sclerosis (MS) are far less likely than those without the condition to have the molecular hallmarks of ...
The results of routine blood tests could be used to speed up cancer diagnosis among people with stomach pain or ...
Data from the Anti-Amyloid Treatment in Asymptomatic Alzheimer's (A4) study, the first and largest clinical trial of pre-symptomatic Alzheimer's disease, is ...
In a study with 991 adults, scientists at DZNE show that the most common forms of frontotemporal dementia (FTD) as ...
A simple blood test could allow doctors to determine whether a person may be at higher risk for stroke or ...
Researchers from Lund University in Sweden have identified distinct molecular signatures associated with the clinical signs of sepsis that could ...
Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.
Contact: hello@sepoy.net
© 2023 Sepoy.net